Recombinant Human Hsp90 alpha protein (ab78425)
Key features and details
- Expression system: Escherichia coli
- Purity: > 90% SDS-PAGE
- Suitable for: WB
Description
-
Product name
Recombinant Human Hsp90 alpha protein
See all Hsp90 alpha proteins and peptides -
Purity
> 90 % SDS-PAGE.
ab78425 is multi-step chromatographically purified. This protein is >90% pure as determined by SDS-PAGE analysis and western blot analysis. -
Expression system
Escherichia coli -
Accession
-
Protein length
Full length protein -
Animal free
No -
Nature
Recombinant -
-
Species
Human -
Predicted molecular weight
90 kDa -
Amino acids
2 to 732
-
Associated products
-
Related Products
-
sELISA pair antibody
Specifications
Our Abpromise guarantee covers the use of ab78425 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
-
Applications
Western blot
-
Form
Liquid -
Concentration information loading...
Preparation and Storage
-
Stability and Storage
Shipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
Constituents: 1.74% Sodium chloride, 10% Glycerol (glycerin, glycerine), 0.79% Tris HCl, 0.039% Beta mercaptoethanol
General Info
-
Alternative names
- EL52
- epididymis luminal secretory protein 52
- Heat shock 86 kDa
see all -
Function
Molecular chaperone. Has ATPase activity. -
Sequence similarities
Belongs to the heat shock protein 90 family. -
Post-translational
modificationsISGylated. -
Cellular localization
Cytoplasm. Melanosome. Identified by mass spectrometry in melanosome fractions from stage I to stage IV. - Information by UniProt
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
Datasheets and documents
-
SDS download
-
Datasheet download
References (1)
ab78425 has been referenced in 1 publication.
- Zhou J et al. A first-in-class Polymerase Theta Inhibitor selectively targets Homologous-Recombination-Deficient Tumors. Nat Cancer 2:598-610 (2021). PubMed: 34179826